FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market

March 2006

FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market.

FDA advisors now say that OTC epinephrine inhalers DON'T offer an important health benefit...and SHOULDN'T be exempt from the ban on CFC propellants.

Wyeth is trying to reformulate Primatene Mist. But it could take 5 years for the new version to be tested and approved.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote